We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Oryx International Growth Fund Ltd | LSE:OIG | London | Ordinary Share | GG00B3BTVQ94 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-10.00 | -0.86% | 1,150.00 | 1,150.00 | 1,210.00 | 1,160.00 | 1,160.00 | 1,160.00 | 1,625 | 16:35:23 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Unit Inv Tr, Closed-end Mgmt | -10M | -12.98M | -0.9269 | -12.51 | 162.4M |
Date | Subject | Author | Discuss |
---|---|---|---|
13/12/2012 12:37 | Impressive, but markets have been pretty strong of late. | topvest | |
13/12/2012 11:41 | Like buses you wait for one and you get two!! October NAV £3.25 November NAV £3.40!!! Discount to NAV will surely lead to share buy backs now, Im glad they represent what I have been posting recently that the fund is really going from strength to strength, also glad I have been adding. | stluke | |
11/12/2012 08:15 | Interesting mid markey buy yesterday of 15,000 shares possibly share buy back? Yesterdays increase in BQE was worth approx £0.5 million by the way. Edit - GLE still on the up now £1.75, that equates to an increase in value of £1.5m approx since end of september this year, again not reflected in the share price yet. | stluke | |
10/12/2012 10:37 | Slightly disappointed with the lack of NAV statement for October and have chased Oryx for this, will update if I here anything. With regard to recent events the portfolio is performing very well with the top holdings in particular outperforming. 1 - CVS 30/9/12 £1.48, 30/11/12 £1.66 - now £1.68 2 - GLE 30/9/12 £1.33, 30/11/12 £1.60 - now £1.73 3 - GPG 30/9/12 £0.28, 30/11/12 £0.295 - now £0.305 4 - BQE 30/9/12 £1.32, 30/11/12 £1.36 - now £1.55 (up 14% today on sunday tip) None of these moves have been reflected in the market yet so will add with confidence of a further move up shortly. | stluke | |
27/11/2012 20:04 | They have said that before on the unquoted portfolio - the sales seem to be taking longer than expected. Could be some good profits on these though if and when they get them away as they are good businesses. | topvest | |
27/11/2012 08:09 | Interims out and they paint a picture of recovery and strength in the period to September. Lots of good info regarding investment holdings which will aid future analysis, will try and do a update to november today based on updated info. A certain paragraph also caught my eye regarding investment banks have been appointed to realise value in the unquoted investments which could result in "a good uplift from current valuations" | stluke | |
24/11/2012 14:10 | Things has definately improved over the past week with now 11 up and 6 down on the main UK quoted portfolio since the start of the month and again more encouragingly the biggest holdings are all up. On the week 9 up, 6 no change and only 1 down. Highlights have been, ECK on good interims and GLE which continues to go from strength to strength. All pointing towards a further rise in the Net Asset Value for the month of November. Should get October's update early next week. | stluke | |
21/11/2012 09:55 | I have 6 shares in OIG - no idea where they came from - could anyone help and tell me what the original company was called please? | gucci | |
17/11/2012 08:56 | Well that was a some what muted response to what were good trading updates, I guess in the case of GLE it has had a good run of late and I understand some have taken profits. I expect both to move forward again soon. Looking at the portfolio as a whole at mid month its been a bit of a mixed bag with a even number of risers and fallers, some of the fallers have been significant like MEC and JNY. Despite this I would suggest the portfolio is still up as 7 of the top 9 stocks by holding value are up in other words all the fallers are the minor stocks in the portfolio. | stluke | |
16/11/2012 07:54 | Fairly decent start to the month until yesterday when one of the mid range holdings had a bit of a shocker, MEC down 12%. Fortunately we have finally got two of the IMS I was banging on about from GLE and BQE both top 3 holdings in OIG portfolio, and worth the wait they were. | stluke | |
09/11/2012 16:36 | Only back to where we were the other day though, NAS which is also managed by Chris Mills via Harwood Capital has really pushed on over the past few months which you would have thought would have happened here as well as the portfolio has many of the same investments the biggest is actually OIG itself! Been doing some digging on the unquoted companies held by OIG and NAS via companies house and they look very promising, the NAS results to July 2012 mention that Bionostic Holdings Limited, Orthoproducts Limited and Nastor all of which OIG have interests in as well are all up for sale and I quote " the impact on the company's net asset value and cash position would be significant although there can be no guarantees" that they will be sold basically. The nature of unquoted investments will mean they have a much lower value placed on them by OIG and the market but if value is realised via a sale the impact could be significant to the share price. | stluke | |
09/11/2012 16:25 | Bit of a jump today. | battlebus2 | |
06/11/2012 19:34 | Very strange share price movement NAV up 22p since mid price went to £2.55, now down to £2.40 with a NAV of £3.22!? I also predict this to grow as per my previous post, will add further. | stluke | |
02/11/2012 09:38 | Based on data as at 31st August as this was the last date holdings information is available, there was 9 stocks up 7 down and 1 unchanged in October of the UK quoted stocks. More importantly of the 6 largest holdings 5 were up and 1 unchanged. The star was definately MJ Gleeson (GLE) which is the 2nd largest holding and was up almost 12% which equates to approx £500,000 gain in value, the biggest holding CVS Group also had a strong month also adding approx £250,000 in value, they did also sold a quantity of this holding and locked in a decent gain. The worst performer QRT was down 6% but has recently rebounded on 3rd quarter update yesterday. Difficult to predict with any great accruacy the movement in terms of share price but should come in up again this month but nearer 8-10p, however this is subject to movement in valuation of the unquoted stocks. | stluke | |
01/11/2012 08:07 | Will do an update tonight if I get time otherwise at the weekend of the month end position. Updates from some companies slow coming through but we do have one from QRT this morning which again was fairly solid, plenty more to come this month. | stluke | |
25/10/2012 16:35 | Not a bad prediction if I don't say so myself! Seriously though it is good to see that my calculations are in the ballpark area and supported. Share price discrepency between market capital and NAV now standing at 67p and on course to grow further in October, share price will have to respond shortly but hopefully not before pay day! | stluke | |
25/10/2012 07:45 | Yes, great news from JNY. GPG to become Coats. Had a look at GPG a few months back, but don't like the pension liabilities in Coats. | topvest | |
25/10/2012 07:38 | Good news out of both JNY and GPG today with blue opens to come, still waiting on a few more trading statements before end of month, should also get an updates NAV statement today, I'm expecting around £3.22. | stluke | |
21/10/2012 15:35 | Bit of a mixed bag this week with CVSG & GLE contining their strong runs of late, couple of weak stocks this though with QRT, RPC and AUG slipping, all in all most stocks still up this month and with a couple of trading updates this week to come should be interesting. | stluke | |
18/10/2012 09:06 | First of the Interim Management Statements out this morning from Mecom and was a in line against the backdrop of tough market conditons for them, cost controls will result in lower than expected debt levels seems to have been well received from the market. | stluke | |
14/10/2012 11:56 | Time for a mid month update I think, the results below show a good start to the month with a couple of strong gainers, SPH, QRT and AUG probably the best, with JNY the worst perfoming stock. In total 10 up 2 no change and 5 down. Mid Price as 30/09/12 as 14/10/12 SPH 26.875 28.75 QRT 145.00 157.50 JNY 4.00 3.625 GLE 134.50 141.50 TIG 21.625 22.25 NARS 60.75 60.25 RPC 426.10 428.00 DODS 4.00 4.125 AUG 35.50 38.00 ESS 18.50 21.00 ECK 14.25 13.875 CMX 94.00 93.50 MEC 83.25 80.00 ASTO 299.50 307.50 CVSG 151.50 158.50 BQE 134.50 134.50 GPG 27.00 27.00 With trading statements due from 4 companies between now and end of month should be a interesting period. | stluke | |
01/10/2012 13:18 | Cracking start to the month with CVSG showing no signs of stopping, GLE also continuing good run since results, both those are in the top 3 holdings. Also seen some nice moves today on SPH up nearly 10% and QRT up over 5%. Fallers are minor but will always be mentioned if noticeable. | stluke | |
29/9/2012 15:35 | Further to yesterdays rises in certain holdings you can add GLE with late rise, quick calculation on yesterdays moves should add a further £300,000 approx so expecting to see the fund to have grown by over £2,000,000 in September. | stluke | |
28/9/2012 14:50 | A couple of holdings down today including AUG which was the one stock out of the top 10 that is down in the month of September, results out the other day suggested trading was tough but profits held up and guidance unchanged, i think the fall was down to CEO resigning and stock was on a good run prior so not to concerned. Moving to the positive a number of holdings today have seen decent gains, QRT, CMX, CVSG and TIG! Will revisit my september prediction at the weekend. | stluke | |
27/9/2012 19:32 | Following on from last posting re expected gains in September. Quick calculation of Aug - Sept movement on 10 top holdings as at 31st August shows 9 advanced with one faller and that was from recent highs, that equated roughly to £1.75m capital growth. Obviously not the whole portfolio but they represent approx 65%, some smaller holdings have had good performances like Essenden (ESS) up 60% this month. | stluke |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions